Suzanne Louise Topalian

Dr. Topalian is Professor of Surgery at Johns Hopkins University School of Medicine. As the Director of the Melanoma Program, Dr. Topalian's current work focuses on modulating immune checkpoints such as PD-1 in cancer therapy, and discovering biomarkers predicting clinical outcomes following treatment. Her pioneering efforts have opened new avenues of scientific interest and clinical investigation in cancer immunology, and have helped to establish immunotherapy as a treatment modality for cancer. Dr. Topalian received her undergraduate degree from Wellesley College and her medical degree from Tufts University School of Medicine.